What does ibogaine feel like? The experience lasts 12–24 hours and does not resemble any other psychedelic compound. It begins physically — a metallic taste, a buzzing sensation through the body, then a rapid loss of coordination that makes walking impossible. What follows is a waking, biographical dream that most people describe as something that happened to them rather than something they chose. Less a trip, more an extended accounting that cannot be stopped or paused.
The Physical Onset
The first signs appear 30–60 minutes after ingestion. Body temperature shifts. A vibrating or buzzing sensation spreads through the limbs. Then comes ataxia — a loss of motor coordination that makes standing, let alone walking, impossible for most of the active experience. This is not a side effect to manage. It is the baseline physical state for 12–24 hours. The ceremony is conducted lying down in a dim, quiet room for a reason.
Ibogaine causes extreme sensitivity to light and sound. At peak intensity, a door closing in an adjacent room can feel intrusive. Ordinary ambient sound becomes difficult to filter. The sensory environment during ceremony is kept controlled not as atmosphere but as medical necessity.
Nausea is common in the first hours, often accompanied by purging. For most people, the physical discomfort is concentrated in the first two to four hours and subsides as the experience deepens. Heart rate changes throughout. Some people report a high-pitched ringing or buzzing in the ears — a phenomenon that can persist for days after the ceremony ends.
None of this is comfortable. Anyone who has been told that ibogaine is a manageable or pleasant psychedelic experience has been given an incomplete description.
What Happens to Vision
After two to three hours, the visual field shifts. Eyes closed, most people encounter geometric patterns first — traceries of light, fractal structures, the common entry point for many plant medicines. Then something distinct happens: the imagery becomes biographical.
This is the quality that sets ibogaine apart from most psychedelics. The visions are not abstract or primarily symbolic. They are specific. Memories surface — childhood scenes, past relationships, pivotal moments the person had not consciously thought about in years. The visual quality varies. Some people describe it as watching a film of their own life, sequential and undeniable. Others describe being inside the memory — experiencing it rather than observing it. Others describe a state in which they are simultaneously present in the scene and watching themselves from outside.
The content is not under the person's control. Iboga shows what it decides to show. People who arrive with a specific issue they intend to address during the ceremony frequently encounter something else entirely. The medicine has its own logic about what needs to be seen, and that logic does not always align with what the person wanted to address.
This is not universally experienced as a problem. The things iboga selects are often the things that most need attention — which is precisely why the person had been avoiding them.
The Interrogative Character
The biographical content is not simply surfaced — it is examined. People consistently report feeling as though they are being asked to see themselves clearly, without the usual defenses available to them. Rationalisations that have held for years become visible as rationalisations. Patterns that seemed like fixed personality become visible as patterns formed under specific conditions and maintained by specific choices.
This is what practitioners mean when they describe ibogaine as an interrogative medicine. It does not deliver insights so much as it removes the option of not seeing them. The question iboga tends to ask — in whatever form it takes for a given person — is some version of: what are you actually doing, and why?
Some people encounter this as clarifying, even freeing. Others encounter it as confrontational and uncomfortable — which, in the context of this work, is often the same thing. Ibogaine does not produce the euphoric interconnectedness associated with MDMA, or the ego dissolution produced by 5-MeO-DMT. There is no oceanic bliss. What it produces is closer to an extended period of forced honesty, conducted over 12–24 hours with no available exit.
What Ibogaine Does with Craving
One of the most consistently reported effects — and the basis of most of the clinical research — is that ibogaine interrupts craving. For people with opioid use disorder, cravings that have been constant for years frequently disappear during and immediately after the ceremony. Opioid withdrawal is substantially reduced. The mechanism involves changes at the opioid receptor level and upregulation of GDNF (glial cell line-derived neurotrophic factor), a protein involved in neuronal survival and differentiation.
The Stanford study published in Nature Medicine in February 2023 documented outcomes in 30 special operations veterans with PTSD, traumatic brain injury, and treatment-resistant depression. At one month post-treatment: 88% reduction in PTSD symptoms, 87% in depression symptoms, 81% in anxiety symptoms. Conventional antidepressant research considers a 50% reduction in depression scores a strong response. The study has methodological limits — 30 is a small population, and there is no placebo arm — but its direction is consistent with what practitioners have observed for decades. A $50 million clinical trial across UTMB, UTHealth Houston, Texas A&M University, and Baylor University followed the Stanford findings.
The experience itself does not explain the craving interruption. The pharmacological mechanism runs in parallel to the phenomenological one. What most people report is that the thing that had organised their behaviour for months or years is substantially reduced, or absent, in the days after ceremony. The work of integration determines whether it stays that way.
Who This Experience Is Not For
Ibogaine cannot be safely administered to someone with QT prolongation or significant cardiac arrhythmia. The medicine prolongs the QT interval throughout the 12–24 hour active experience. The pre-ceremony EKG identifies this condition before ceremony rather than during. Any provider offering ibogaine without requiring an EKG is not operating safely, regardless of how they describe their programme or their safety record.
People currently taking SSRIs or SNRIs are not candidates without a completed, physician-supervised taper. The risk is serotonin syndrome — potentially fatal. This is not a factor to weigh against potential benefit. It is an absolute contraindication. The same applies to lithium, methadone without a completed transition protocol, and certain antipsychotic medications.
People with active psychosis or schizophrenia-spectrum disorder are not appropriate candidates. People in acute psychiatric crisis — genuinely destabilised, not simply in a difficult period — are not appropriate candidates. The experience amplifies what is present. Entering it in acute instability does not produce stability.
People primarily seeking a mystical experience, a shortcut to insight, or a way of feeling something significant without the sustained work of change afterward are likely to be disappointed. The medicine does not deliver what people hope for. It delivers what they need — which, for someone arriving with those expectations, is frequently a very uncomfortable confrontation with the gap between the two.
For a full list of contraindications and what screening involves, see the FAQ.
The Days After
The active experience fades over 24 hours. The pharmacological effect does not end there. Noribogaine — ibogaine's primary metabolite — remains biologically active for weeks to months after a single ceremony, sustaining a period of elevated neuroplasticity during which new patterns are substantially more accessible than usual. This is the integration period.
Integration support is not a bonus service — it determines whether the ceremony produces lasting change. The ceremony opens the neuroplasticity window. What is done during that window is the primary determinant of long-term outcomes. Providers who hand people a pamphlet at the end of the experience and wish them luck are not providing ibogaine treatment. They are providing ibogaine. The two are not the same thing.
The pattern that recurs in people for whom ceremony did not hold: they left with genuine clarity and reduced craving, returned to the same environment, the same relationships, the same unaddressed conditions that produced the original problem — and found, six weeks later, that they were back where they started. The ceremony did not fail. The window closed with nothing different put into it.
Integration coaching at Transcend costs $150–$300 CAD per 60–90 minute session. A practical baseline for most people is 3–5 sessions concentrated in the weeks immediately following ceremony — when noribogaine activity is highest and the neuroplasticity window is most active. More on what a complete programme involves is on the integration page.
Is This Right for You?
Ibogaine ceremony is appropriate for people who have not responded to conventional treatment, who clear medical screening, and who are prepared to do the work in the weeks that follow. It is demanding. It is not comfortable for most people. It is not a first resort, and it is not appropriate for everyone.
The ceremony page describes what the programme at Transcend includes: the on-site physician throughout the 12–24 hour experience, continuous cardiac ECG monitoring, whole Tabernanthe iboga root bark in the Bwiti tradition, and 2–3 days of supervised recovery. If you are considering applying, the application begins with a direct conversation, not a booking form. We respond to every application within 2–3 business days. Integration support is worth arranging before the ceremony. The window opens immediately.